pharmaceutical lawyers

A Philadelphia jury ordered Johnson & Johnson subsidiary Janssen Pharmaceuticals to pay $8 billion in a drug-induced gynecomastia matter.  26-year-old Nicholas Murray developed abnormally large breasts in 2003. He had been taking Risperdal, an antipsychotic drug, to control his autism spectrum disorder symptoms. In a statement, J&J said it would appeal the “grossly disproportionate” award.…Read the article

The U.S. Food and Drug Administration’s voluntary blood pressure drug recall continues as Torrent Pharmaceuticals Limited announced it is expanding its nationwide recall to include two blood pressure medications that were found to contain trace amounts of a potential cancer-causing carcinogen. The two medications are 3 lots of Losartan Potassium Tablets USP and 2 lots…Read the article

You Are What You Eat High sodium and low potassium diets may contribute to teenage depression, according to a new study. This finding may impact both patients and providers. Such a diet indicates many processed foods and few fresh fruits and vegetables. Researchers at the University of Alabama-Birmingham found a conclusive link between depression and…Read the article

If you caught our last article, What You Need to Know About Taxotere, the experienced pharmaceutical litigation team at Napoli Shkolnik PLLC explored what Taxotere is and why it is a dangerous pharmaceutical linked to permanent hair loss in breast cancer survivors treated with this drug. In short, Taxotere is an FDA-approved chemotherapy drug that…Read the article

Chemotherapy has proven to be an effective way to combat the signs, symptoms, and effects of a wide variety of cancers, including breast cancer. When used, chemotherapy can increase the chance of a cure, reduce the likelihood that cancer will return, and can help breast cancer patients live a longer life. However, this treatment is…Read the article

The U.S. Food and Drug Administration (FDA) issued a warning in late August 2018 about the link between diabetic medications and a rare, yet life-threatening disease called Fournier’s gangrene. The warning is specific to certain FDA-approved inhibitors (SGLT2), which are said to prevent the kidneys from reabsorbing sugar into the blood, therefore helping lower blood…Read the article